© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
198338 |
As an accredited 6-(1-Bromoethyl)-4-Chloro-5-Fluoropyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-(1-Bromoethyl)-4-Chloro-5-Fluoropyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Once in a while, a compound comes along that quietly fits into modern chemistry’s jigsaw—6-(1-Bromoethyl)-4-chloro-5-fluoropyrimidine stands out as one of those pieces. It’s not just another pyrimidine derivative; detailed design and a well-thought substitution pattern make this molecule a handy partner where selective reactivity and functional diversity are needed. In any chemist’s toolbox, versatility means more than a buzzword, especially with scarce time, rising costs, and the pressure to deliver results. Researchers and development chemists keep circling back to 6-(1-Bromoethyl)-4-chloro-5-fluoropyrimidine because it brings together bromine, chlorine, and fluorine atoms on a pyrimidine ring in a way that plays well with a long list of synthetic tricks—both simple and advanced.
From the perspective of a working scientist, one of the most relevant talking points around this molecule stems from its widespread use as a building block in pharmaceutical research. Medicinal chemistry teams often choose this compound as a stepping stone for making complex nucleoside analogs, kinase inhibitors, or even antiviral candidates. Why pick this over something else? The answer sits in the unique combination of functional groups: the presence of bromine at the side chain makes for smooth Suzuki or Buchwald reactions, opening paths to attach nearly anything with an aryl or alkyl group. The chloro and fluoro substitutions on the pyrimidine core offer further regime-shifting selectivity, allowing multi-step reactions without troublesome side products. I’ve seen assay-ready fragments appear on the bench top much faster thanks to this compound, cutting weeks off synthesis cycles.
If you compare this compound with its cousins—say, simple 4-chloropyrimidine or even 5-fluoropyrimidine—the added bromoethyl chain turns into a game-changer. Bromo groups, especially when paired with a lateral ethyl, act as both a leaving group and a guide for selective chain growth. If you want a new pharmacophore or want to try a targeted active-site probe, having this handle means rapid customization. Both chlorine and fluorine load the core with different electron-withdrawing strengths, which significantly influences reactivity and biological fit. In contrast, single-substituted pyrimidines fall short in offering this breadth of modifiability.
Actual bench experience tells more than datasheets ever can. Researchers appreciate compounds that resist decomposition, don’t fume or degrade when left out briefly, and stay consistent from lot to lot. With 6-(1-Bromoethyl)-4-chloro-5-fluoropyrimidine, storage at room temperature in dry conditions is usually enough. No foul odors, no color change, and minimal need for elaborate hazards training. NMR and HPLC results show high purity in most reliable offerings, saving headaches over cleaning up messes from side products. Process scale-up, often a risky territory, tends to go smoothly, cutting the learning curve for those new to heterocyclic intermediates. From my own projects, having dependable access to a pure stock saves batch work and lets the team focus on downstream steps.
Not all halogens play the same role in medicinal chemistry. Bromine brings a sweet spot for further functionalization—easy for nucleophilic substitution, just right for palladium-catalyzed coupling. Chlorine, holding the 4-position, offers sharp selectivity in reactions and defends against unwanted rearrangements. The small, highly electronegative fluorine on the 5-position tweaks both the electronic nature and metabolic stability, a feature often exploited to make more durable drug candidates. Unlike bulkier or harder-to-manage halogen mixes, this trio fits into classic synthetic sequences. Making lead compounds isn’t just about picking an attractive scaffold; it’s about keeping chemistries flexible without endless purification.
On the drug discovery side, much of the fascination with 6-(1-Bromoethyl)-4-chloro-5-fluoropyrimidine emerges from its ability to enable rapid analog generation. High-throughput screening runs lean on compounds that can morph quickly into a new variant—changing a single atom often triggers major changes in biological function. With this molecule, small adjustments yield fresh candidates. Medicinal chemists appreciate an intermediate that links their ideas to actual testable compounds. My old team regularly turned to this scaffold when the hits dried up; sometimes, a tweak at the bromo site or a swap for the chlorine or fluorine made a flat line on an IC50 chart pop upward.
Efficient synthesis isn’t just a matter of pride; it shapes budget realities, environmental footprints, and even project go/no-go decisions. The accessible starting reagents and mild conditions for working with this molecule mean lower solvent waste and fewer harsh catalysts. Scale-up doesn’t require excessive cooling or specialized containment—a plus for green chemistry goals. More straightforward purification steps help drive down costs and support companies trying to hit both economic and sustainability targets. With regulatory agencies shining a spotlight on both safety and greener processes, choosing cleaner intermediates delivers dividends beyond just bottom-line savings.
Chemists rarely own the luxury of perfect conditions. In one of my projects trying to tweak a metabolic pathway blocker, basic pyrimidines kept failing due to stubborn selectivity problems. Switching to 6-(1-Bromoethyl)-4-chloro-5-fluoropyrimidine allowed site-specific attachment, solving a year-old bottleneck. The bromoethyl group, in particular, let us hang different alkyls until a potent inhibition effect emerged. Instead of derailing the project or eating months in re-design, the team pivoted quickly—all thanks to an intermediate that handled both the chemistry and the urgency.
Modern agriculture pushes for pest and disease control with less environmental risk and more precise effects. For agrochemical researchers, the same benchtop advantages hold sway. Novel active agents for crop protection often rely on heterocyclic intermediates—here the underlying structure supports new options for targeting plant pathogens or insects. Material science labs sometimes use fluorinated pyrimidines to build advanced polymers or as nucleation points in specialty coatings. The ability to swap functional groups and fine-tune electronic properties gives a leg up in applications as diverse as OLEDs and corrosion-resistant films. Analytical labs also stockpile it for method validation or diagnostic kit development, using it as a reference or spiking agent for assay calibration.
Safety underpins every successful lab. Fortunately, 6-(1-Bromoethyl)-4-chloro-5-fluoropyrimidine—unlike some less stable or highly reactive halides—avoids the worst hazards. Wear gloves, work in a fume hood, and keep it dry, as you would with most small-molecule intermediates. I've personally handled several grams during batch synthesis without issue, provided the SOPs stay followed. No explosive decomposition, low volatility, and straightforward procedure documentation keep both new hires and seasoned chemists comfortable. Companies promoting knowledge transfer or in-house training benefit from the manageable risk profile this intermediate offers.
Plenty of basic pyrimidines or simple halogenated aromatics sit on the shelf, but those often demand extra steps, tougher purification, and more aggressive reagents to reach the same synthetic destination. Substituting other halogens, such as iodine for bromine, increases costs and can lead to lower yields or problematic side products. Several well-known analogs might offer cheaper up-front prices, but wasted time and failed experiments quickly erase any apparent savings. With 6-(1-Bromoethyl)-4-chloro-5-fluoropyrimidine, minimal rework helps keep projects moving forward—vital for startups, university labs, and industrial R&D teams alike.
Whether you’re in a bustling pharma plant or a university’s cramped research wing, the basics remain similar: get reliable results without breaking the bank or inviting unnecessary risk. Source reliability matters—a lesson learned the hard way by anyone who has watched a promising synthesis grind to a halt due to contaminated raw material. The major global suppliers have largely maintained good quality standards for this intermediate, evidenced by consistent analytical data and repeatable performance. The academic circle often leverages this reliability for grant-driven projects, where margins for error—and budgets—run thin.
Trust gets built by seeing results, not just reading brochures. Plenty of synthesis projects start with the right intentions and stall out due to unpredictable reactions or poorly characterized reagents. In my work, switching to a cleaner, more precisely designed intermediate can mean the difference between a single-week experiment and a quarter-long delay. Chemists in my network stick with intermediates that won’t throw unexpected curveballs, both because they save effort and because funders—industrial or academic—judge outcomes by productivity as much as ingenuity. 6-(1-Bromoethyl)-4-chloro-5-fluoropyrimidine keeps showing up in product pipelines and in the footnotes of peer-reviewed publications, a quiet testament to broad confidence.
An often-overlooked benefit touches the less tangible energies a good intermediate brings to the lab environment. When a project stalls while troubleshooting route design, having something as flexible as this enables hands-on learning for junior chemists. Supervising new team members trying their hand at palladium-catalyzed coupling or learning flash chromatography feels less risky; they have a forgiving substrate to practice on, and the feedback loop between error and correction happens faster. Those lessons keep morale up and turn early-career missteps into usable expertise, without piling on costs or risking larger strategic failures.
Science grows through exchange—not just of data, but of practical resources and lessons earned in the field. From the perspective of a writer-experimenter, I’ve found that intermediates that foster open sharing, reproducibility, and easy access build a more resilient research community. Labs with more flexible intermediates often end up collaborating across borders, since it’s easier to share protocols, reproduce published results, and submit results for review. That stacks up to greater trust in published findings, a crucial advantage in an era where cross-validation and open science keep gaining ground.
No tool works for every job. Over-reliance on a single intermediate can dull creativity; teams sometimes fall back on familiar routes even when better options might exist. Sometimes, too, regulatory guidelines on halogenated compounds change, affecting waste treatment or worker exposure rules unexpectedly. While 6-(1-Bromoethyl)-4-chloro-5-fluoropyrimidine avoids the harshest hazards, improper storage—moisture or contamination—can degrade quality, so vigilance around stockroom practices stays critical. Some specialized transformations could favor other scaffolds or substitution patterns; not every drug target responds to pyrimidine cores, so multidisciplinary assessment always earns its keep.
Chemists looking to make a bigger impact with fewer resources would do well to consider both the legacy and real-world performance of intermediates like this one. The next wave of ingredient innovation—targeted therapies, advanced biomaterials, sustainable agrochemicals—depends on reliable, fine-tunable building blocks that don’t bog teams down with extra work. Seasoned researchers and early-career scientists alike get more room for ideas and experimentation, not just because the compound excels at what it does, but because it clears the path for new directions.
Labs investing in reliable supply chains can avoid many interruptions. Building stronger partnerships with specialty chemical suppliers leads to better forecasting and bulk pricing, lessening the odds of production bottlenecks. Delivering regular training for safe and effective use pays off, especially as graduate cohorts and technicians cycle through. Longer term, supporting efforts to develop greener manufacturing routes for pyrimidine intermediates would lessen both cost and compliance burdens. From personal experience, coordinating with colleagues who work at manufacturing sites has often resulted in process tweaks that paid dividends in waste reduction and labor savings.
For many, 6-(1-Bromoethyl)-4-chloro-5-fluoropyrimidine starts as a tool. Watch closely, and it becomes a bridge—linking shifts in science, the daily grind of real labs, and the broader push for rapid, responsible advances. Chemists value resources that are reliable, empowering, and genuinely adaptable—not because the literature says so but because daily results and the livelihoods of teams depend on it. Whether you’re running a multi-million-dollar R&D portfolio or seeking a single pivotal data point for a new hypothesis, the right intermediate makes science less about firefighting and more about focused progress. If recent history in the field tells us anything, it's that practical, smart choices often fuel the breakthroughs others only talk about.
